Sunil Healthcare share news and announcements

NSE: SUNLOCBSE: 537253Pharmaceuticals & BiotechnologySmall Cap

₹69.00₹4.90 (7.64%)BSE ₹70.00

Share price at the NSE close on 23 Oct 2026. Previous close ₹64.10.

52-week range of BSE trades to 23 Oct 2026

₹56.35Low, 7 Apr 2026₹82.31High, 1 Sep 2026

Market cap: ₹71 Cr3,191st largest listed
P/E: 19.9
P/B: 1.0
Dividend yield: Nonein the last 12 months
ROE: 5.2%
ROCE: 4.9%
Debt to equity: 0.80
Volume, NSE: 24658.9% delivered

Sunil Healthcare share news and announcements

463 announcements, routine notices left out, newest first. Page 3 of 10.

Feb 2023
- 2 Feb · Board meeting
  Meeting on 14 Feb 2023: quarterly results
- 2 Feb · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 14/02/2023 ,inter alia, to consider and approve Inter alia, to consider, approve .... (opens in a new tab)
Nov 2022
- 15 Nov · Management
  In accordance with Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Mr. Satyendu Pattnaik, who is appointed as Company Secretary and Compliance .... (opens in a new tab)
- 15 Nov · Management
  30 of the SEBI (LODR) Regulations, 2015, the Board of Directors in its Meeting held on 14th November, 2022 has appointed Mr. Satyendu Pattnaik .... (opens in a new tab)
- 14 Nov · Board meeting
  We are pleased to inform that, the Board of Directors of the Company at their Board Meeting held today on Monday, November .... (opens in a new tab)
- 14 Nov · Results
  Approved Unaudited Financial Results (Standalone & consolidated) for the 2nd quarter/1st half year ended on September 30, 2022 of the financial year 2022-23 and noted Limited Review Report .... (opens in a new tab)
- 4 Nov · Board meeting
  Meeting on 14 Nov 2022: quarterly results
- 4 Nov · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 14/11/2022 ,inter alia, to consider and approve Board Meeting scheduled to .... (opens in a new tab)
Oct 2022
- 13 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 4 Oct · Management
  Disclosure of material information as per Regulation 30 and Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 .... (opens in a new tab)
Sep 2022
Aug 2022
Jul 2022
- 20 Jul · Results
  Unaudited Financial Results (Standalone & consolidated) for the 01st quarter ended June 30, 2022 of the Financial Year 2022-23 and noted Limited Review Report on the same (opens in a new tab)
- 20 Jul · Results
  We are pleased to inform, inter-alia the outcome of the Meeting of the Board of Directors of the Company held on Wednesday, .... (opens in a new tab)
- 14 Jul · Board meeting
  Meeting on 20 Jul 2022: quarterly results and annual general meeting
- 13 Jul · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 20/07/2022 ,inter alia, to consider and approve and take on record the Un-Audited .... (opens in a new tab)
- 1 Jul · Rating
  This is to inform that credit rating for bank facilities done by Care ratings Limited vide its letter no. CARE/DRO/RL/2022-23/1410 dated June 30, 2022. Care Rating revised the long term .... (opens in a new tab)
Jun 2022
- 21 Jun · Results
  Details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly <a href="https://www.bseindia.com/stock-share-price/meetings/voting-results/537253 ....
- 20 Jun · Results
  Declaration of voting results of 01st Postal Ballot/2022-23 along with scrutinizer Report (opens in a new tab)
May 2022
Apr 2022
- 28 Apr · Board meeting
  Meeting on 6 May 2022: quarterly results and audited results
- 28 Apr · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 06/05/2022 ,inter alia, to consider and approve and take on record the Audited .... (opens in a new tab)
- 7 Apr · Compliance Under Regulation 40(10) Of The SEBI (LODR) Reg 2015 For FY 2021-22
  Compliance Certificate dt. 07.04.2022 issued by PCS under Regulation 40(10) of the SEBI (LODR) Reg 2015 for FY 2021-22 (opens in a new tab)
- 7 Apr · Compliance Certificate For Period Ended On March 31, 2022
  Compliance Certificate for period ended on March 31, 2022 duly signed by RTA and Company Secretary of the Company. (opens in a new tab)
- 7 Apr · Statement Of Investor Complaints For The Quarter Ended March 2022
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 2 Apr · Legal
  This is with reference to your email dated 01.04.2022, where clarification is sought, with respect to significant movement of Price at BSE of our Security in recent past. In this connection, .... (opens in a new tab)
- 1 Apr · Legal
  Exchange has sought clarification from Sunil Healthcare Ltd on April 1, 2022 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Feb 2022
- 18 Feb · Legal
  Clarification with respect to significant movement of Price at BSE of our Security in recent past. (opens in a new tab)
- 17 Feb · Legal
  Exchange has sought clarification from Sunil Healthcare Ltd on February 17, 2022 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Jan 2022
- 31 Jan · Results
  Results for third quarter ended on 31-12-2021 (opens in a new tab)
- 31 Jan · Results
  The 247th Board Meeting was held through video conferencing mode and started at 3:30 p.m. on 31-01-2022 and concluded at 4:30 p.m. Duly signed outcome alongwith results are attached. (opens in a new tab)
- 24 Jan · Board meeting
  Meeting on 31 Jan 2022: quarterly results
- 22 Jan · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 31/01/2022 ,inter alia, to consider and approve the Un-audited Financial .... (opens in a new tab)
- 20 Jan · Shareholding for the Period Ended December 31, 2021
  Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click ....
- 8 Jan · Statement Of Investor Complaints For The Quarter Ended December 2021
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Dec 2021
- 9 Dec · Rating
  This is to inform that credit rating for bank facilities done by Care ratings Limited vide its letter no. CARE/DRO/RR/2021-22/1461 dated December 08, 2021. Care Rating reaffirmed the long .... (opens in a new tab)
Oct 2021
- 27 Oct · Results
  Un-Audited Results Cum Limited Review Report (opens in a new tab)
- 27 Oct · Board meeting
  We are pleased to inform, inter-alia the outcome of the Meeting of the Board of Directors of the Company held on Wednesday, .... (opens in a new tab)
- 14 Oct · Board meeting
  Meeting on 27 Oct 2021: quarterly results
- 14 Oct · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 27/10/2021 ,inter alia, to consider and approve and take on record the Un-audited .... (opens in a new tab)

Sunil Healthcare share news and announcements

Feb 2023

Nov 2022

Oct 2022

Sep 2022

Aug 2022

Jul 2022

Jun 2022

May 2022

Apr 2022

Feb 2022

Jan 2022

Dec 2021

Oct 2021